Phase I Study of Pazopanib in Combination with Paclitaxel and Carboplatin Given Every 21 Days in Patients with Advanced Solid Tumors

Title
Phase I Study of Pazopanib in Combination with Paclitaxel and Carboplatin Given Every 21 Days in Patients with Advanced Solid Tumors
Authors
Keywords
-
Journal
MOLECULAR CANCER THERAPEUTICS
Volume 11, Issue 8, Pages 1820-1828
Publisher
American Association for Cancer Research (AACR)
Online
2012-06-08
DOI
10.1158/1535-7163.mct-11-0997

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started